Tromethamine

Tromethamine

SCHEMBL112367

N.NC(CO)(CO)CO

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

DHFRGARTPTGFRPTGIRPTGS1PTGS2TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8envmurAthyA

The experimentally established mechanism targets of Tromethamine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tromethamine SCHEMBL3995787 1.00 MEN1 (0.91)
Tromethamine SCHEMBL1417748 0.96 MEN1 (0.83)
Tromethamine SCHEMBL975 0.95
Tromethamine SCHEMBL17484 0.95 MEN1 (1.00)
Tromethamine SCHEMBL3696191 0.95
Tromethamine SCHEMBL4950340 0.92 MEN1 (0.77)
Tromethamine SCHEMBL6427079 0.91
Tromethamine SCHEMBL7126002 0.91
Tromethamine SCHEMBL7091147 0.91
Tromethamine SCHEMBL6063594 0.91

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 293 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118806690-A In-situ gel preparation and application thereof 润佳(苏州)医药科技有限公司 2024-10-22 CN claimed
CN-117488341-A Self-supporting catalyst for producing hydrogen by electrolyzing water and preparation method thereof 江苏天合元氢科技有限公司 2024-02-02 CN claimed
US-20230149285-A1 DENTAL COMPOSITION COMPRISING CHELATOR AND BASE PRIMAL THERAPIES, INC. 2023-05-18 US claimed
US-11491100-B2 Dermal composition comprising chelator and base PRIMAL THERAPIES, INC. (US) 2022-11-08 US claimed
US-20190262255-A1 DENTAL COMPOSITION COMPRISING CHELATOR AND BASE PRIMAL THERAPIES, INC. 2019-08-29 US claimed
US-20160030327-A1 DENTAL COMPOSITION COMPRISING CHELATOR AND BASE ABOVA FINANCIAL, INC. 2016-02-04 US claimed
EP-2968083-A1 DENTAL COMPOSITION COMPRISING CHELATOR AND BASE Stein, Emily A. (US) 2016-01-20 EP claimed
CN-104125962-A Tetracyclic anthraquinone derivatives TIANJIN HEMAY BIO TECH CO LTD 2014-10-29 CN claimed
WO-2014159659-A1 DENTAL COMPOSITION COMPRISING CHELATOR AND BASE STEIN EMILY A (US) 2014-10-02 WO claimed
US-20090236571-A1 STABLE, WATER-SOLUBLE NEAR INFRARED DYES EPOLIN, INC. 2009-09-24 US claimed
US-5624546-A Method and apparatus for the detection of toxic gases MIL-RAM TECHNOLOGY, INC. (US) 1997-04-29 US claimed
US-5348159-A Enhancement of polycyanoacrylate-developed fingerprints HER MAJESTY THE QUEEN IN RIGHT OF CANADA AS REPRESENTED BY THE SOLICITOR GENERAL OF CANADA (CA) 1994-09-20 US claimed
EP-4660194-A1 SALT AND CRYSTAL FORM OF CYCLOALKENE COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jiangsu Hansoh Pharmaceutical Group Co., Ltd. (CN) 2025-12-10 EP disclosed
US-20250340544-A1 GLP-1 Receptor Agonists and Uses Thereof PFIZER INC. (US) 2025-11-06 US disclosed
US-12378230-B2 GLP-1 receptor agonists and uses thereof PFIZER INC. (US) 2025-08-05 US disclosed
EP-4219487-B9 GLP-1 RECEPTOR AGONISTS AND USES THEREOF PFIZER (US) 2025-03-26 EP disclosed
WO-1989005798-A1 TROMETHAMINE SALT OF 1-METHYL-beta-OXO-alpha-(PHENYLCARBAMOYL)-2-PYRROLEPROPIONITRILE CIBA-GEIGY AG (CH) 1989-06-29 WO disclosed
US-4231750-A Methods for performing chemical assays using fluorescence and photon counting DIAGNOSTIC REAGENTS, INC. (US) 1980-11-04 US disclosed
US-4211845-A 3,3',5,5'-TETRAMETHYLBENZIDINE AND SYRINGALDAZINE AS CHROMOGENS MILES LABORATORIES, INC. (US) 1980-07-08 US disclosed
US-3959289-A PROPHYLACTICS IN ALLERGIES THE UPJOHN COMPANY (US) 1976-05-25 US disclosed